This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Comments
Loading...

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • BMO Capital analyst Jack Matten initiated coverage on Prudential Financial, Inc. PRU with an Underperform rating and announced a price target of $101. Prudential Financial shares closed at $117.35 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Kevin Dede initiated coverage on Exodus Movement, Inc. EXOD with a Buy rating and announced a price target of $50. Exodus Movement shares closed at $41.00 on Wednesday. See how other analysts view this stock.
  • Piper Sandler analyst Yasmeen Rahimi initiated coverage on Bright Minds Biosciences Inc. DRUG with an Overweight rating and announced a price target of $93. Bright Minds Biosciences shares closed at $33.35 on Wednesday. See how other analysts view this stock.
  • Raymond James analyst Daniel Magder initiated coverage on Electrovaya Inc. ELVA with a Strong Buy rating and announced a price target of $4.5. Electrovaya shares closed at $2.52 on Wednesday. See how other analysts view this stock.
  • Roth MKM analyst Chip Moore initiated coverage on Innventure, Inc. INV with a Buy rating and announced a price target of $16. Innventure shares closed at $12.42 on Wednesday. See how other analysts view this stock.

Considering buying PRU stock? Here’s what analysts think:

Read This Next:

DRUG Logo
DRUGBright Minds Biosciences Inc
$28.76-%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
99.91
Price Trend
Short
Medium
Long
Got Questions? Ask
How will Prudential Financial react after downgrade?
Which analysts agree on Exodus Movement potential?
What market trends benefit Bright Minds Biosciences?
Could Electrovaya see significant growth soon?
What factors drive Innventure to outperform expectations?
How might healthcare stocks be impacted by these ratings?
Are there ETFs that align with these analyst ratings?
Which sectors could benefit from shifts in investor sentiment?
How do analyst ratings influence stock volatility?
What other stocks might follow Electrovaya's trend?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: